Home › IGA Glomerulonephritis › Utah › Salt Lake City
IGA Glomerulonephritis clinical trials in Salt Lake City, UT
3 studies for IGA Glomerulonephritis are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN
RecruitingPhase 2
- Utah Kidney Research Institute, Salt Lake City
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
RecruitingPhase 3
- Prim Childrens Hosp Inv Pharm, Salt Lake City
Study of BHV-1400 in IgA Nephropathy
RecruitingPhase 1
- Site-016, Salt Lake City
IGA Glomerulonephritis trials in other cities
- Houston, TX9 studies
- Orlando, FL5 studies
- New York City, NY4 studies
- Denver, CO4 studies
- Los Angeles, CA4 studies
- Pembroke Pines, FL3 studies
- Philadelphia, PA3 studies
- Boston, MA3 studies
- Cedar Rapids, IA3 studies
- Columbus, OH3 studies
- Miami, FL3 studies
- Sioux City, IA3 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Breast Cancer27 studies
- Cancer (all types)25 studies
- Colorectal Cancer22 studies
- Multiple Myeloma22 studies
- Ovarian Cancer19 studies
- Lung Cancer19 studies
- Melanoma19 studies
- Metastatic Cancer17 studies
- Heart Failure17 studies
- Acute Myeloid Leukemia17 studies
- Obesity16 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.